Pulmonary Hypertension Community Call — May

The identification of ubiquitous risk factors determining long-term morbidity is crucial in infants born prematurely when aiming to develop prevention strategies.

Use of subcutaneous treprostinil (TRE) in children with pulmonary hypertension (PH) secondary to lung disease (group 3 PH) is not well described. We hypothesized that initiation of TRE is associated with improvement in PH severity and right ventricular (RV) function with minimal early side effects. 

In this PH Community Call, we discussed: 

• C–C Motif chemokine receptor-2 blockade ameliorates PH in rats and synergizes with a pulmonary vasodilator
• Deep-learning networks accurately detect pulmonary hypertension in patients with idiopathic pulmonary fibrosis
• Assessing the feasibility of using smartphone data to identify risk of idiopathic pulmonary arterial hypertension

The first, Women's Health Task Force, webinar of 2026, exploring how biological sex influences pulmonary arterial hypertension (PAH) and respiratory disease.